Literature DB >> 551196

The use of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves.

C G Stewart, A Immelman, P Grimbeek, D Grib.   

Abstract

Twenty splenectomized Afrikander/Simmentaler cross animals were used. Eight of these were naturally infected with Anaplasma marginale while 12 were infected artificially. When the packed cell volume was reduced to between 24% and 20% during the post splenectomy relapses or primary infections, six animals were treated with a single injection of 20 mg/kg of long acting oxytetracycline (LA) and seven animals were treated on two successive days with 10 mg/kg of short acting oxytetracycline (SA). The remaining seven animals served as untreated controls. Both drugs were effective in controlling A. marginale reactions. No deaths occurred in the group of animals treated with oxytetracycline LA and they showed a longer relapse interval and higher blood levels of oxytetracycline compared to those treated with oxytetracycline SA. A single death occurred in the latter group. Four deaths occurred in the control group which also had the shortest relapse interval.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 551196

Source DB:  PubMed          Journal:  J S Afr Vet Assoc        ISSN: 1019-9128            Impact factor:   1.474


  2 in total

1.  Seroprevalence of Anaplasma marginale in 2 Iowa feedlots and its association with morbidity, mortality, production parameters, and carcass traits.

Authors:  Johann F Coetzee; Peggy L Schmidt; Annette M O'Connor; Michael D Apley
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

2.  First Survey on the Presence and Distribution of Oxytetracycline-Resistance Genes in Anaplasma Species.

Authors:  Parisa Shahbazi; Sahar Nouri Gharajalar; Kolsoum Mohebbi; Jafar Taeb; Hosein Hashemzadeh Farhang; Ali Abbas Nikvand; Roghayeh Norouzi
Journal:  Acta Parasitol       Date:  2020-11-12       Impact factor: 1.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.